Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster.
Syrian hamster
acute lung injury
acute respiratory distress syndrome
adenovirus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
30 05 2020
30 05 2020
Historique:
received:
05
05
2020
revised:
25
05
2020
accepted:
27
05
2020
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
20
2
2021
Statut:
epublish
Résumé
Adenovirus (Ad) infections are usually mild and self-limited, with minimal inflammatory responses. During worldwide outbreaks, Ad14p1, an emerging Ad14 variant, has caused severe pulmonary disease, including acute respiratory distress syndrome (ARDS). This increased pathogenicity of Ad14p1 is not completely understood. In initial studies, we observed that infection of Syrian hamsters with Ad14p1 can cause a patchy bronchopneumonia, with an increased intensity of inflammation, compared to wild type Ad14 infection. The current study compared the dynamics of the immunopathogenesis of Ad14 and Ad14p1 infection of hamster lungs through the first two weeks after infection. Little difference was seen in infection-induced inflammation at day 1. Beginning at day 3, Ad14p1-infected hamsters showed marked inflammation that continued through to day 7. The inflammation began to resolve by day 10 but was still detectable at day 14. In contrast, Ad14-infected hamsters showed little inflammation during the 14-day period of observation. Inflammatory cell type analysis revealed that, at day 1, hamsters infected with either virus had predominantly neutrophil infiltration that began to resolve by day 3. However, at day 5, Ad14p1-infected hamsters had a second wave of neutrophil infiltration that was accompanied by edema which persisted to a variable extent through to day 10. These differences were not explained by an increased Ad14p1 replication rate, compared with Ad14 in vitro, but there was prolonged persistence of Ad14p1 in hamster lungs. There were differences in lung tissue cytokine and chemokine responses to Ad14p1 vs. Ad14 infection that might account for the increased leukocyte infiltrates in Ad14p1-infected hamsters. This animal model characterization provides the basis for future translational studies of the viral genetic mechanisms that control the increased immunopathogenesis of the emergent, Ad14p1 strain.
Identifiants
pubmed: 32486177
pii: v12060595
doi: 10.3390/v12060595
pmc: PMC7354616
pii:
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : P20GM109007
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109007
Pays : United States
Références
Toxicol Pathol. 2015 Dec;43(8):1074-92
pubmed: 26296628
J Virol. 1987 May;61(5):1466-72
pubmed: 3573145
Am J Physiol Lung Cell Mol Physiol. 2017 Jul 1;313(1):L138-L153
pubmed: 28408365
Euro Surveill. 2011 Feb 24;16(8):
pubmed: 21371411
Influenza Other Respir Viruses. 2013 Nov;7(6):1048-54
pubmed: 23692915
Nat Med. 2011 Jan;17(1):96-104
pubmed: 21151137
Immunol Cell Biol. 2017 Jan;95(1):108-116
pubmed: 27528076
Genomics. 2013 Nov-Dec;102(5-6):448-55
pubmed: 24055951
J Clin Virol. 2012 Jul;54(3):265-8
pubmed: 22484030
J Infect Dis. 2007 Nov 15;196(10):1465-73
pubmed: 18008225
Hum Gene Ther. 1995 Dec;6(12):1553-60
pubmed: 8664380
Emerg Microbes Infect. 2017 Nov 1;6(11):e92
pubmed: 29089589
J Virol. 2012 Jun;86(12):7019-20
pubmed: 22628402
Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
pubmed: 21531958
J Virol. 1993 Jan;67(1):101-11
pubmed: 8380066
J Heart Lung Transplant. 2007 Dec;26(12):1229-42
pubmed: 18096473
PLoS Pathog. 2018 Mar 9;14(3):e1006914
pubmed: 29522575
J Virol. 2014 Mar;88(5):2658-69
pubmed: 24352454
Respir Res. 2010 Aug 25;11:116
pubmed: 20738863
J Virol. 2017 Apr 28;91(10):
pubmed: 28250128
J Immunol Methods. 2011 May 31;368(1-2):24-35
pubmed: 21334343
Virology. 2015 Nov;485:305-12
pubmed: 26319212
J Infect Dis. 2009 May 15;199(10):1419-26
pubmed: 19351260
Hum Gene Ther. 1998 Oct 10;9(15):2207-22
pubmed: 9794205
Am J Hyg. 1957 Mar;65(2):119-29
pubmed: 13410904
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10409-11
pubmed: 10468621
J Infect Dis. 2010 Jul 15;202(2):214-22
pubmed: 20533881
Hum Gene Ther. 1994 Jun;5(6):731-44
pubmed: 7948135
PLoS One. 2013;8(3):e60345
pubmed: 23555956
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Cancer Res. 2006 Feb 1;66(3):1270-6
pubmed: 16452178
Emerg Infect Dis. 2013 Jan;19(1):119-22
pubmed: 23260201
J Public Health (Oxf). 2015 Mar;37(1):64-9
pubmed: 24573364
mBio. 2017 Aug 1;8(4):
pubmed: 28765216
J Immunol. 2008 Aug 1;181(3):2134-44
pubmed: 18641352
Virology. 2009 May 10;387(2):436-41
pubmed: 19307010
Pulm Circ. 2018 Apr-Jun;8(2):2045894018766737
pubmed: 29521174
PLoS One. 2015 Jul 13;10(7):e0131201
pubmed: 26168049
J Virol. 2015 Oct 21;90(1):497-505
pubmed: 26491152
Clin Infect Dis. 2008 Feb 1;46(3):421-5
pubmed: 18173356
Emerg Infect Dis. 2011 Aug;17(8):1402-8
pubmed: 21801616
J Infect Dis. 2009 May 15;199(10):1427-34
pubmed: 19351259
J Infect Dis. 2010 Jul 1;202(1):93-103
pubmed: 20500088